A Novel Online Calculator to Predict Long-term Survival and Recurrence Risk of Patients With Gastric Adenocarcinoma

NCT06337266 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3622

Last updated 2024-03-29

No results posted yet for this study

Summary

This study aimed to develop a novel Prognostic Oxidative Stress-Immune-Inflammatory Score (POSII Score) and introduce an innovative online calculator designed to predict long-term survival and assess the recurrence risk of gastric cancer (GC).

Conditions

Sponsors & Collaborators

  • Fujian Medical University Union Hospital

    collaborator OTHER
  • Fujian Medical University

    lead OTHER

Principal Investigators

  • Changming Huang, M.D. · Fujian Medical University Union Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-08-20
Completion
2024-03-19

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06337266 on ClinicalTrials.gov